Medicare Enrolled
Dr. Mohammed Alo, DO
Cardiovascular Disease · Toledo, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alo
Dr. Mohammed Alo is a cardiovascular disease specialist in Toledo, OH, with 17 years of NPI registration. Based on federal Medicare data, Dr. Alo performed 2,351 Medicare services across 1,763 unique beneficiaries.
Between the years covered by Open Payments, Dr. Alo received a total of $7,653 from 43 pharmaceutical and/or device companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 23% volume in OH
$7,653 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,351
Medicare services
Top 23% in OH for cardiovascular disease
1,763
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~138 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
587 | $86 | $223 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
214 | $10 | $89 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
210 | $91 | $183 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
199 | $102 | $277 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
174 | $130 | $253 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
132 | $58 | $188 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
121 | $5 | $21 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
108 | $73 | $195 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
70 | $80 | $195 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
69 | $55 | $149 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
64 | $20 | $175 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
61 | $119 | $253 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
45 | $19 | $175 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
44 | $73 | $838 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
42 | $10 | $64 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
36 | $13 | $74 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
29 | $138 | $358 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
26 | $75 | $1,743 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
22 | $23 | $168 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
22 | $16 | $100 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
21 | $40 | $163 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
18 | $16 | $120 |
| Implantable defibrillator system check A check of the implanted defibrillator device to ensure it is functioning correctly. This evaluation covers single, dual, or multiple lead systems. |
15 | $44 | $240 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
11 | $17 | $145 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
11 | $98 | $219 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.3% high complexity
4.1% medium
90.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,653
Total received (2018-2024)
Avg $1,093/year across 7 years
Top 25% in OH for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
294
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,215 (94.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$438 (5.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$529
2023
$1,294
2022
$1,193
2021
$1,202
2020
$750
2019
$1,448
2018
$1,237
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Kestra Medical Technology Services, Inc.
$391
Amgen Inc.
$56
Kiniksa Pharmaceuticals International, plc
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Novartis Pharmaceuticals Corporation
$14
Novo Nordisk Inc
$14
AstraZeneca Pharmaceuticals LP
$13
Top 3 companies account for 89.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$795
Kestra Medical Technology Services, Inc.
$734
AstraZeneca Pharmaceuticals LP
$687
Boehringer Ingelheim Pharmaceuticals, Inc.
$685
Novartis Pharmaceuticals Corporation
$621
Amgen Inc.
$577
PFIZER INC.
$512
Esperion Therapeutics, Inc.
$382
Amarin Pharma Inc.
$309
Astellas Pharma US Inc
$308
SANOFI-AVENTIS U.S. LLC
$217
Janssen Scientific Affairs, LLC
$214
AtriCure, Inc.
$153
E.R. Squibb & Sons, L.L.C.
$131
Actelion Pharmaceuticals US, Inc.
$130
NOVARTIS PHARMACEUTICALS CORPORATION
$127
Boston Scientific Corporation
$117
ABIOMED
$95
Merck Sharp & Dohme LLC
$88
Collegium Pharmaceutical, Inc.
$79
Philips Electronics North America Corporation
$76
Gilead Sciences, Inc.
$75
Regeneron Healthcare Solutions, Inc.
$62
Kiniksa Pharmaceuticals, Ltd.
$45
Lundbeck LLC
$44
Daiichi Sankyo Inc.
$39
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$37
Assertio Therapeutics, Inc.
$31
Novo Nordisk Inc
$29
Teva Pharmaceuticals USA, Inc.
$27
Merck Sharp & Dohme Corporation
$24
Kiniksa Pharmaceuticals International, plc
$23
IBSA Pharma Inc.
$22
Bayer HealthCare Pharmaceuticals Inc.
$20
Jazz Pharmaceuticals Inc.
$18
Inari Medical, Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
Lilly USA, LLC
$16
Radius Health, Inc.
$16
Bardy Diagnostics, Inc.
$15
BioDelivery Sciences International, Inc.
$14
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$12
Palette Life Sciences, Inc.
$9
Top 3 companies account for 29.0% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (5050) Ext Holter · (5050) Extended Holter · AJOVY · ATRICLIP LAA EXCLUSION SYSTEM · ATRICURE SYNERGY ABLATION SYSTEM · Arcalyst · Assure WCD · BELBUCA · BRILINTA · BUNAVAIL 2.1 mg 30-count box · CAMZYOS · CHANTIX · Carnation Ambulatory Monitor · Corlanor · Deflux · ELIQUIS · EMGALITY · ENTRESTO · FARXIGA · FLOWTRIEVER CATHETER · Gralise · INVOKANA · Impella · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LOKELMA · LifeVest · MULTAQ · Morphabond ER · NEXLETOL · NEXLIZET · NORTHERA · OPSUMIT · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Ranexa · Repatha · S · Tirosint · Tymlos · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN Access System · WATCHMAN FLX · XARELTO · XTAMPZA · XYWAV · ZIPSOR
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
74
Per 100K population
17.3
County median income
$60,095
Nearest hospital
MERCY ST VINCENT MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alo is a clinical cardiology specialist, with above-average Medicare volume (top 23% in OH), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Alo performed 587 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alo receive payments from pharmaceutical companies?
Yes. Dr. Alo received a total of $7,653 from 43 companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alo's costs compare to other cardiologists in Toledo?
Dr. Alo's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Toledo
Browse cardiologists in Toledo ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in OH
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in OH
Which OH cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Kestra Medical Technology Services, Inc. Payments to Doctors
See all physicians who received payments from Kestra Medical Technology Services, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology